Literature DB >> 9222609

A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosine kinase, heat shock transcription factor Hsf1, and the aryl hydrocarbon receptor.

S C Nair1, E J Toran, R A Rimerman, S Hjermstad, T E Smithgall, D F Smith.   

Abstract

A variety of regulatory proteins, including different classes of transcription factors and protein kinases, have been identified in complexes with Hsp90. On careful examination of unactivated progesterone receptor complexes, eight different protein participants have been identified, and each can be considered a component of the cytoplasmic molecular chaperone machinery. These proteins are Hsp90, Hsp70, Hip, p60, p23, FKBP51, FKBP52 and Cyp40. Studies in a cell-free assembly system have helped to define a highly ordered, dynamic pathway for assembly of progesterone receptor complexes. In the present study, target proteins other than progesterone receptor were used in this cell-free system to assemble complexes in vitro and to compare the composition of resulting complexes. Targets used were human estrogen receptor, human Fes protein-tyrosine kinase, human heat shock transcription factor Hsf1, and human aryl hydrocarbon receptor. The striking similarity of resulting target complexes with previously characterized progesterone receptor complexes suggest that each of these targets undergoes a common assembly pathway involving multiple chaperone components in addition to Hsp90.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9222609      PMCID: PMC376461          DOI: 10.1379/1466-1268(1996)001<0237:apomci>2.3.co;2

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  60 in total

1.  Multiple components of the HSP90 chaperone complex function in regulation of heat shock factor 1 In vivo.

Authors:  S Bharadwaj; A Ali; N Ovsenek
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor.

Authors:  A Kazlauskas; S Sundström; L Poellinger; I Pongratz
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  The Hsp90 chaperone complex A potential target for cancer therapy?

Authors:  Beatrice D Darimont
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

Review 4.  p23, a simple protein with complex activities.

Authors:  Sara J Felts; David O Toft
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

Review 5.  Cdc37 goes beyond Hsp90 and kinases.

Authors:  Morag MacLean; Didier Picard
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

Review 6.  On mechanisms that control heat shock transcription factor activity in metazoan cells.

Authors:  Richard Voellmy
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

7.  Identification of SSF1, CNS1, and HCH1 as multicopy suppressors of a Saccharomyces cerevisiae Hsp90 loss-of-function mutation.

Authors:  D F Nathan; M H Vos; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  p23 protects the human aryl hydrocarbon receptor from degradation via a heat shock protein 90-independent mechanism.

Authors:  Beverly Pappas; Yujie Yang; Yu Wang; Kyung Kim; Hee Jae Chung; Michael Cheung; Katie Ngo; Annie Shinn; William K Chan
Journal:  Biochem Pharmacol       Date:  2018-03-17       Impact factor: 5.858

9.  HSP90 interacts with and regulates the activity of heat shock factor 1 in Xenopus oocytes.

Authors:  A Ali; S Bharadwaj; R O'Carroll; N Ovsenek
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors.

Authors:  Joleen Hubbard; Charles Erlichman; David O Toft; Rui Qin; Bridget A Stensgard; Sara Felten; Cynthia Ten Eyck; Gretchen Batzel; S Percy Ivy; Paul Haluska
Journal:  Invest New Drugs       Date:  2010-01-15       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.